Cost-effectiveness analysis of rotavirus vaccination among Libyan children using a simple economic model

References

• Berry SA, Johns B, Shih C, Berry AA, Walker DG. The cost-effectiveness of rotavirus vaccination in Malawi. J Infect Dis. 2010; 202: S108–15. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Cortese MM, Parashar UD, Centers for Disease Control and Prevention . Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009; 58: 1–25. [PubMed Abstract].
   Google Scholar
• Patel M, Pedreira C, De Oliveira LH, Tate J, Orozco M, Mercado J, etal. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA. 2009; 301: 2243. [PubMed Abstract].
   Google Scholar
• Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J. 2011; 30: S1. [PubMed Abstract].
   Google Scholar
• WHO. Generic protocol for monitoring impact of rotavirus vaccination on gastroenteritis disease burden and viral strains. 2008. Switzerland: Department of Immunization, Vaccines and Biologicals.
   Google Scholar
• Valencia-Mendoza A, Bertozzi S, Gutierrez JP, Itzler R. Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico. BMC Infect Dis. 2008; 8: 103. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Khoury H, Ogilvie I, El Khoury AC, Duan Y, Goetghebeur MM. Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population. BMC Infect Dis. 2011; 11: 9. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• NCIRS. Rotavirus vaccines for Australian children. 2009; Australia: National Centre for Immunization Research & Surveillance.
   Google Scholar
• Gray J, Vesikari T, Damme V. Economic burden of rotavirus disease. J Pediatr Gastroenterol Nutr. 2008; 46: S24–S31. [PubMed Abstract].
   Google Scholar
• Bilcke J, Van Damme P, De Smet F, Hanquet G, Van Ranst M, Beutels P. The health and economic burden of rotavirus disease in Belgium. Eur J Pediatr. 2008; 167: 1409–19. [PubMed Abstract].
   Google Scholar
• Constenla DO, Linhares AC, Rheingans RD, Antil LR, Waldman EA, da Silva LJ. Economic impact of a rotavirus vaccine in Brazil. J Health Popul Nutr. 2008; 26: 388. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Standaert B, Harlin O, Desselberger U. The financial burden of rotavirus disease in four countries of the European Union. Pediatr Infect Dis J. 2008; 27: S20.
   Web of Science ®Google Scholar
• Masters J. Gastroenteritis and the rotavirus vaccine. 2007; UK: Health University of Bristol.
   Google Scholar
• Catherine T-R. Rotavirus live, oral, pentavalent vaccine. Clin Therapeut. 2007; 29: 2724–37.
   Web of Science ®Google Scholar
• CDC. Rotavirus vaccine. 2010; Atlanta, GA: National Immunization Program, US Department of Health and Human Service.
   Google Scholar
• NNII. Rotavirus. Available from: http://www.immunizationinfo.org/vaccines/rotavirus [cited 2 December 2010]..
   Google Scholar
• Payne J, Elliott E. Gastroenteritis in children. Clin Evid. 2009; 2009: 0314.
   Google Scholar
• Tate JE, Rheingans RD, O'Reilly CE, Obonyo B, Burton DC, Tornheim JA, etal. Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in Kenya. J Infect Dis. 2009; 200: S76–84. [PubMed Abstract].
   Google Scholar
• Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y. Economic impact of a rotavirus vaccination program in Mexico. Rev Panam Salud Pública. 2009; 25: 481–90.
   PubMed Web of Science ®Google Scholar
• Soárez PC, Valentim J, Sartori AMC, Novaes HMD. Cost-effectiveness analysis of routine rotavirus vaccination in Brazil. Rev Panam Salud Pública. 2008; 23: 221–30.
   Web of Science ®Google Scholar
• Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI. Cost-effectiveness and potential impact of rotavirus vaccination in the United States. Pediatrics. 2007; 119: 684. [PubMed Abstract].
   Google Scholar
• WHO. Generic protocols for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. 2002. Switzerland: Vaccines and Biologicals, World Health Organization.
   Google Scholar
• CDC. Rotavirus surveillance – Worldwide, 2001–2008. MMWR Morb Mortal Wkly Rep. 2008; 57: 1255–7.
   Google Scholar
• World Bank. Countries and economies. 2012; Libya. Available from: http://data.worldbank.org/country/libya [cited 13 May 2014]..
   Google Scholar
• Bakir M, Standaert B, Turel O, Bilge ZE, Postma M. Estimating and comparing the clinical and economic impact of paediatric rotavirus vaccination in Turkey using a simple versus an advanced model. Vaccine. 2013; 31: 979–86. [PubMed Abstract].
   Google Scholar
• WHO. WHO vaccine-preventable diseases: monitoring system. 2013 global summary. 2013. Available from: http://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria[country][]=LBY&commit=OK [cited 26 March 2014]..
   Google Scholar
• WHO. Statistics. 2012. Available from: http://www.who.int/countries/lby/en/ [cited 9 November 2014]..
   Google Scholar
• General Authority for Information. 2009. Statistical book. Libya Government.
   Google Scholar
• National Statistics. Full report – women in the labour market. 2013. Available from: http://www.ons.gov.uk/ons/dcp171776_328352.pdf [cited 13 May 2014]..
   Google Scholar
• Tate JE, Panozzo CA, Payne DC, Patel MM, Cortese MM, Fowlkes AL, etal. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics. 2009; 124: 465. [PubMed Abstract].
   Google Scholar
• Guilbert J. The world health report 2002-reducing risks, promoting healthy life. Educ Health (Abingdon). 2003; 16: 230.
   PubMedGoogle Scholar
• WHO. WHO guide for standardization of economic evaluations of immunization programmes. 2008; Switzerland: WHO. 58–68.
   Google Scholar
• Standaert B, Ethgen O, Emerson R, Postma M, Mauskopf J. Comparing cost-effectiveness results for a vaccine across different countries worldwide: what can we learn?. Adv Ther. 2014; 31: 1095–108. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• NCDC. Annual report for infectious disease in Libya. 2009. Libya: Surveillance Department, National center for Diseases Control.
   Google Scholar
• WHO. Tables of costs and prices used in WHO-CHOICE analysis. 2007. Available from: http://www.who.int/choice/costs/CER_thresholds/en/ [cited 22 March 2014]..
   Google Scholar
• Kim S-Y, Goldie SJ, Salomon JA. Cost-effectiveness of rotavirus vaccination in Vietnam. BMC Public Health. 2009; 9: 29. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Sato T, Nakagomi T, Nakagomi O. Cost-effectiveness analysis of a universal rotavirus immunization program in Japan. Jpn J Infect Dis. 2011; 64: 277–83. [PubMed Abstract].
   Google Scholar
• Suwantika AA, Tu HAT, Postma MJ. Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account. Vaccine. 2013; 31: 3300–7. [PubMed Abstract].
   Google Scholar
• Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T. Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries. Rev Panam Salud Pública. 2007; 21: 205–16.
   PubMed Web of Science ®Google Scholar
• Chotivitayatarakorn P, Chotivitayatarakorn P, Poovorawan Y. Cost-effectiveness of rotavirus vaccination part of the National Immunization Program for Thai children. Southeast Asian J Trop Med Publ Health. 2010; 41: 114.
   PubMed Web of Science ®Google Scholar
• Bilcke J, Van Damme P, Beutels P. Cost-effectiveness of rotavirus vaccination: exploring caregiver (s) and “no medical care” disease impact in Belgium. Med Decis Making. 2009; 29: 33–50. [PubMed Abstract].
   Google Scholar
• Jit M, Edmunds W. Evaluating rotavirus vaccination in England and Wales: part II. The potential cost-effectiveness of vaccination. Vaccine. 2007; 25: 3971–9. [PubMed Abstract].
   Google Scholar
• Melliez H, Levybruhl D, Boelle P, Dervaux B, Baron S, Yazdanpanah Y. Cost and cost-effectiveness of childhood vaccination against rotavirus in France. Vaccine. 2008; 26: 706–15. [PubMed Abstract].
   Google Scholar
• Tilson L, Jit M, Schmitz S, Walsh C, Garvey P, McKeown P, etal. Cost-effectiveness of universal rotavirus vaccination in reducing rotavirus gastroenteritis in Ireland. Vaccine. 2011; 29: 7463–73. [PubMed Abstract].
   Google Scholar